01541.HK
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
HKSE · Healthcare · Biotechnology · CN
HKD 3.40
+0.29%Next report
Analyst consensus
- Next report date
- Mar 30, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 26, 2026
- EPS actual
- -HKD 0.44
- EPS estimate
- —
- Revenue actual
- HKD 29.3M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Mar 30, 2027